Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1095 | 963 | 1095 | 1212 | 1446 | 2213 |
Fund Return | 9.49% | -3.74% | 9.49% | 6.61% | 7.66% | 8.27% |
Place in category | 1237 | 1806 | 1237 | 779 | 734 | 389 |
% in Category | 60 | 87 | 60 | 44 | 49 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LansfOrsakringar Global Indexnara | 129.61B | 32.61 | 14.20 | 13.96 | ||
Lansforsakringar USA Indexnara | 52.44B | 40.26 | 17.14 | 16.89 | ||
Lansforsakringar Sverige Indexnara | 37.42B | 9.05 | -0.28 | 8.93 | ||
Lansforsakringar Global Hallbar A | 25.27B | 30.84 | 11.43 | 12.36 | ||
Lansforsakringar Global Hallbar B | 25.27B | 31.23 | 11.76 | 12.63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SPP Aktiefond Europa | 17.88B | 12.91 | 8.15 | 8.84 | ||
Swedbank Robur Access Europa | 16B | 12.77 | 8.39 | 8.85 | ||
Handelsbanken Europafond Index | 12.87B | 11.79 | 7.34 | 8.62 | ||
Handelsbanken European Index utd | 12.87B | 11.79 | 7.34 | 8.13 | ||
AMF Aktiefond Europa | 8.07B | 9.18 | 6.64 | 8.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 3.39 | 722.70 | +2.26% | |
Novo Nordisk B | DK0062498333 | 3.37 | 607.3 | +0.60% | |
SAP | DE0007164600 | 3.09 | 268.500 | +0.17% | |
Nestle | CH0038863350 | 2.62 | 77.48 | -1.53% | |
AstraZeneca | GB0009895292 | 2.46 | 11,344.0 | +0.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review